Related Experiment Video
Updated: May 20, 2026

09:51
Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web
Published on: July 16, 2017
AtlasCBS: a web server to map and explore chemico-biological space
Alvaro Cortés-Cabrera1, Antonio Morreale, Federico Gago
1Departamento de Farmacología, Universidad de Alcalá, 28871, Alcalá de Henares, Madrid, Spain.
Journal of Computer-Aided Molecular Design
|July 17, 2012
Summary
Ligand Efficiency Indices (LEI) offer a new way to select drug candidates. The AtlasCBS server visualizes compound data using LEI, improving early-stage drug discovery and design.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Drug Discovery
Background:
- Small-molecule drug discovery faces high failure rates, necessitating improved methods for compound selection.
- Ligand Efficiency Indices (LEI) are emerging as powerful metrics for early-stage compound evaluation.
- Effective visualization tools are crucial for interpreting complex biological and chemical data.
Purpose of the Study:
- To introduce the AtlasCBS server, a web tool for visualizing drug discovery data.
- To demonstrate how Ligand Efficiency Indices can be used to represent target-ligand interactions.
- To facilitate the selection and prioritization of promising drug candidates.
Main Methods:
- Development of the AtlasCBS server, which processes target-ligand databases.
- Generation of two-dimensional dynamical representations based on Ligand Efficiency Indices.
- Integration of public databases (BindingDB, PDBBind, ChEMBL) and support for proprietary datasets.
Main Results:
- AtlasCBS provides a unique atlas-like representation of compound data using LEI.
- The server effectively decouples chemical (angular) and biological (radial) properties of ligands.
- Visualizations aid in understanding structure-activity relationships and prioritizing compounds.
Conclusions:
- The AtlasCBS server offers a valuable resource for enhancing early-stage drug discovery.
- LEI-based visualizations represent a significant advancement in drug design strategies.
- This approach holds promise for reducing failure rates in small-molecule drug development.
